ArticleCells2019

Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models.

Heng Sheng Sow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.